These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37499961)

  • 21. DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Fas(lpr/lpr) mice in vivo.
    Lenert P; Yasuda K; Busconi L; Nelson P; Fleenor C; Ratnabalasuriar RS; Nagy PL; Ashman RF; Rifkin IR; Marshak-Rothstein A
    Arthritis Res Ther; 2009; 11(3):R79. PubMed ID: 19476613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ophiopogonin D attenuates the progression of murine systemic lupus erythematosus by reducing B cell numbers.
    Nie Y; Li C; Sun N
    J Biochem Mol Toxicol; 2023 Jul; 37(7):e23361. PubMed ID: 36999444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic effects of the artemisinin analog SM934 on lupus-prone MRL/lpr mice via inhibition of TLR-triggered B-cell activation and plasma cell formation.
    Wu Y; He S; Bai B; Zhang L; Xue L; Lin Z; Yang X; Zhu F; He P; Tang W; Zuo J
    Cell Mol Immunol; 2016 May; 13(3):379-90. PubMed ID: 25942599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toll-like receptor 7 agonist imiquimod prevents the progression of SLE in MRL/lpr mice via inhibiting the differentiation of T follicular helper cells.
    Duan X; Shen C; Zhang X; Wu L; Chen J; Ma B; Wang Q; Sun P; Lan Y; Su C
    Int Immunopharmacol; 2020 Mar; 80():106239. PubMed ID: 32007709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IgG4 Autoantibodies Attenuate Systemic Lupus Erythematosus Progression by Suppressing Complement Consumption and Inflammatory Cytokine Production.
    Pan Q; Xiao H; Shi L; He Y; Cai J; Wu J; Li A; Ye L; Yang C; Liu HF
    Front Immunol; 2020; 11():1047. PubMed ID: 32625200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The PBX1 lupus susceptibility gene regulates CD44 expression.
    Niu Y; Sengupta M; Titov AA; Choi SC; Morel L
    Mol Immunol; 2017 May; 85():148-154. PubMed ID: 28257976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TIGIT-Fc fusion protein alleviates murine lupus nephritis through the regulation of SPI-B-PAX5-XBP1 axis-mediated B-cell differentiation.
    Zhao J; Li L; Feng X; Gao C; Gao L; Zhan Y; Wang Z; Zhao M; Yin H; Lu Q
    J Autoimmun; 2023 Sep; 139():103087. PubMed ID: 37481835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Norcantharidin ameliorates the development of murine lupus via inhibiting the generation of IL-17 producing cells.
    Du LJ; Feng YX; He ZX; Huang L; Wang Q; Wen CP; Zhang Y
    Acta Pharmacol Sin; 2022 Jun; 43(6):1521-1533. PubMed ID: 34552214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bach2 deficiency leads autoreactive B cells to produce IgG autoantibodies and induce lupus through a T cell-dependent extrafollicular pathway.
    Jang E; Kim UK; Jang K; Song YS; Cha JY; Yi H; Youn J
    Exp Mol Med; 2019 Dec; 51(12):1-13. PubMed ID: 31819031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oridonin ameliorates lupus-like symptoms of MRL(lpr/lpr) mice by inhibition of B-cell activating factor (BAFF).
    Zhou L; Sun L; Wu H; Zhang L; Chen M; Liu J; Zhong R
    Eur J Pharmacol; 2013 Sep; 715(1-3):230-7. PubMed ID: 23712004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. STAT3 Signaling in B Cells Is Critical for Germinal Center Maintenance and Contributes to the Pathogenesis of Murine Models of Lupus.
    Ding C; Chen X; Dascani P; Hu X; Bolli R; Zhang HG; Mcleish KR; Yan J
    J Immunol; 2016 Jun; 196(11):4477-86. PubMed ID: 27183592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus.
    Wen J; Doerner J; Chalmers S; Stock A; Wang H; Gullinello M; Shlomchik MJ; Putterman C
    J Neuroinflammation; 2016 Apr; 13(1):73. PubMed ID: 27055816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prednisone treatment inhibits the differentiation of B lymphocytes into plasma cells in MRL/MpSlac-lpr mice.
    Yan SX; Deng XM; Wang QT; Sun XJ; Wei W
    Acta Pharmacol Sin; 2015 Nov; 36(11):1367-76. PubMed ID: 26456588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolactin promotes proliferation of germinal center B cells, formation of plasma cells, and elevated levels of IgG3 anti-dsDNA autoantibodies.
    Carreón-Talavera R; Santana-Sánchez P; Fuentes-Pananá EM; Legorreta-Haquet MV; Chávez-Sánchez L; Gorocica-Rosete PS; Chávez-Rueda AK
    Front Immunol; 2022; 13():1017115. PubMed ID: 36389691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LRRK2 is involved in the pathogenesis of system lupus erythematosus through promoting pathogenic antibody production.
    Zhang M; Yao C; Cai J; Liu S; Liu XN; Chen Y; Wang S; Ji P; Pan M; Kang Z; Wang Y
    J Transl Med; 2019 Jan; 17(1):37. PubMed ID: 30670047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of FcγRIIB regulates downstream protein phosphorylation and suppresses B cell activation to ameliorate systemic lupus erythematosus.
    Sheng L; Cao X; Chi S; Wu J; Xing H; Liu H; Yang Z
    Int J Mol Med; 2020 Oct; 46(4):1409-1422. PubMed ID: 32945349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating CD138 enhances disease progression by augmenting autoreactive antibody production in a mouse model of systemic lupus erythematosus.
    Liu L; Akkoyunlu M
    J Biol Chem; 2021 Sep; 297(3):101053. PubMed ID: 34364875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The inhibition of autoreactive T cell functions by a peptide based on the CDR1 of an anti-DNA autoantibody is via TGF-beta-mediated suppression of LFA-1 and CD44 expression and function.
    Sela U; Mauermann N; Hershkoviz R; Zinger H; Dayan M; Cahalon L; Liu JP; Mozes E; Lider O
    J Immunol; 2005 Dec; 175(11):7255-63. PubMed ID: 16301630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-ANX A1 Antibody Therapy in MRL/lpr Murine Model of Systemic Lupus Erythematosus.
    Bradyanova S; Mihaylova N; Chipinski P; Manassiev Y; Herbáth M; Kyurkchiev D; Prechl J; Tchorbanov AI
    Arch Immunol Ther Exp (Warsz); 2021 Jul; 69(1):19. PubMed ID: 34322760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AID dysregulation in lupus-prone MRL/Fas(lpr/lpr) mice increases class switch DNA recombination and promotes interchromosomal c-Myc/IgH loci translocations: modulation by HoxC4.
    White CA; Seth Hawkins J; Pone EJ; Yu ES; Al-Qahtani A; Mai T; Zan H; Casali P
    Autoimmunity; 2011 Dec; 44(8):585-98. PubMed ID: 21585311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.